Brief: Acura Pharmaceuticals files for secondary offering of up to $5.0 mln
03/02/2017 22:17
Feb 3 (Reuters) - Acura Pharmaceuticals Inc ACUR.O :
* Files for secondary offering of up to $5.0 million - sec
filing
Source text for Eikon: ID:nEOL8s0xQs
Further company coverage: ACUR.O
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way